MD turned pharma CEO
Novartis CEO Dan Vasella talks with On Leadership's Steve Pearlstein about ignoring Wall Street analysts, doing "beautiful things" for patients and delivering long-term value. Video by: Elizabeth Tenety & Andrea Useem/Washington Post. WATCH MORE: www.washingtonpost.com/leadership
▶︎
Novartis CEO Vas Narasimhan on The David Rubenstein Show
▶︎
Axios’ Dan Primack in conversation with Takeda Pharmaceutical’s Christophe Weber
▶︎
Doku: Die geheime Welt des deutschen Adels
▶︎
MD to Pharma : Getting into Pharma as a Doctor. Alternative careers
▶︎
Novartis's Vasella Says Alcon Deal Wont Affect Ratings: Video
▶︎
"Mr. Novartis" - im Gespräch. Dr. Daniel Vasella bei Leadership Revisited
▶︎
Pharma industry has a trust issue, AstraZeneca CEO says | CNBC Conversation
▶︎
AIM: Congrats to Julie Kim of Takeda on receiving the 2025 Vision Award
▶︎
This Is What Brexit Cost the World
▶︎
Monsanto Scientist Daniel Goldstein Deposition 2.27.2018 | Pilliod Monsanto Trial
▶︎
120 secondes - Le parachute doré de Daniel Vasella
▶︎
James Surowiecki talks with CEO of Novartis AG Dan Vasella - Conversations - The New Yorker
▶︎
Germany’s army chief on AI, drones and the future of the tank | The Economist
▶︎
CEO defends raising drug price 5,000 percent
▶︎
Vasella: «Ich habe zwei Fehler gemacht»
▶︎
The Hard Fall of Porsche
▶︎
Interview with Cuong Do, CEO Biovie Pharma
▶︎
Björn Höcke bricht ZDF-Interview ab und droht
▶︎
Anthony Scaramucci on Trump, MAGA and the US Midterms | The Mishal Husain Show
▶︎